Background: Rheumatic fever (RF) and rheumatic heart disease (RHD) 
INTRODUCTION
Rheumatic fever (RF) and rheumatic heart disease (RHD) are significant causes of cardiovascular disease in young adults and children especially in developing countries. In 1984, The World Health Organization (WHO) in collaboration with the International Society and Federation of Cardiology (ISFC) initiated an International Programme for Prevention of RF and RHD in 16 developing countries in five WHO Regions: Mali, Zimbabwe and Zambia (in Africa); Bolivia, El Salvador and Jamaica (in the Americas); Egypt, Iraq, Pakistan and Sudan (in the Eastern Mediterranean); India, Sri Lanka and Thailand (in South-East Asia); and China, the Phillipines and Tonga (in the Western Pacific). The International Programme received partial funding from the Arab Gulf Fund for United Nations Development (AGFUND) until 2000 (1) .
In July 1985, the Jamaican RF/RHD National Control Programme began as a collaborative effort between the Heart Foundation of Jamaica, the Ministry of Health and the Department of Child Health of The University of the West Indies.
Phase I of the Control Programme began as a pilot project in Kingston and St Andrew. After two years, the programme was extended to all parishes in Phase II. Since 1991, the programme has been run by the Ministry of Health in hospitals and Type 3 clinics throughout Jamaica. Regional Health Authorities, since their inception, have had direct responsibility for the Control Programme in the regions and provide reports to the Head Office of the Ministry of Health.
The RF/RHD Control Programme promotes the primary prevention of RF through identification and appropriate treatment of streptococcal throat infections. The main focus has been secondary prevention (of recurrences) of streptococcal throat infections and RF in persons who have been diagnosed with RF/RHD by administering four-weekly injections of benzathine penicillin. This has involved case finding, registration and surveillance of patients. Health education has been provided to patients, families and the public as well as ongoing training of health personnel. There have been two major national conferences and numerous presentations and seminars on RF and RHD. Many posters, brochures and pamphlets have been distributed. Since the programme began, there have been two retrospective surveys of case records of patients admitted to the major hospitals in Kingston and St Andrew. Survey A was a review of records of 1079 patients admitted in the period 1975 to 1985 and was a case finding exercise at the start of the Programme. Survey B was a review of records of 512 admissions between 1989 and 1995 and was an additional case finding exercise and gave an indication of disease trends (2) .
These surveys provided important data on RF/RHD in Jamaica. Survey A was conducted at the National Chest Hospital, Bustamante Hospital for Children, Kingston Public Hospital and the University Hospital of the West Indies. Survey B was conducted at the same hospitals with the exception of the National Chest Hospital.
Age at Initial Attack of Rheumatic Fever
As has been reported from other countries, most patients were between five years and 15 years of age at the initial attack.
In Survey A, 77% of 524 persons were between five and 15 years of age. In Survey B, 82% of 119 persons were between five and 15 years of age. The youngest child with RF was two years and nine months old. The three oldest patients with RF were 30 years of age. There was no difference in the occurrence of RF between males and females in initial attacks.
Diagnosis of Rheumatic Fever
Rheumatic fever had been diagnosed in 54% of records in Survey A and 55% of records in Survey B. The diagnosis conformed to the modified Jones Criteria.
Severity of Heart Disease
Severe carditis occurred in 7% of 438 patients with initial attacks of RF in Survey A and 26% of 134 patients with initial attacks in Survey B. There was a significantly greater number of cases of severe carditis in Survey B. 
Evidence of Recent Streptococcal Infection in Rheumatic Fever
Records showed evidence of recent streptococcal infection in RF patients in 74% in Survey A and 64% in Survey B. Mitral incompetence was the commonest lesion in patients with rheumatic heart disease in both surveys. Mitral stenosis and then aortic incompetence were next in frequency.
Cost of Hospitalization and Length of Hospital Stay
In 1995, patients admitted to the University Hospital of the West Indies had an average stay of 8.5 days. In Survey B, RF/RHD patients had an average hospital stay of 21 days at a cost of J$105 000.00. It was estimated that the cost of hospitalizing patients with RF/RHD in Survey B was about J$17 million per annum for the three hospitals studied. These costs would translate in 2012 to an average cost of over J$250 000.00 for each patient admitted and a total cost of over J$43 million annually for treating RF/RHD patients admitted to the major hospitals in Kingston and St Andrew. In the era of free healthcare in public institutions, these considerable preventable costs would be borne by taxpayers. The International Rheumatic Fever Study Group in the report "Allergic reactions to long term benzathine penicillin prophylaxis for rheumatic fever" (3), compared the incidence of recurrent attacks of RF in patients on regular prophylaxis with the incidence of recurrence in patients who did not comply.
"Rheumatic fever recurred in 8 (0.45%) of 1790 patients while on regular prophylaxis compared with 11 (11.5%) of 96 who were not". The study provided further evidence that regular four-weekly injections of benzathine penicillin are effective in preventing recurrences of RF.
In the past two years, increasing numbers of patients have received open heart surgery for rheumatic heart disease. Recent data suggest that more careful and continuous attention needs to be paid to the RF/RHD Control Programme regionally and centrally in order to prevent first attacks and recurrences of RF, reduce the burden and severity of RF/RHD for patients and reduce the Ministry of Health expenditure for medical and surgical treatment of RF/RHD. patients with rheumatic fever and rheumatic heart disease and who continue to work to reduce the burden of these diseases. In particular, Ms Eleanor Champagnie, Public Health Nurse, was invaluable in initiating the Control Programme, extending it islandwide and carefully monitoring it in the early years. Public Health Nurse, Mrs Tressie Wallace, has assisted greatly in the conduct of the last hospital survey and the rheumatic fever prophylaxis clinic at the University Hospital of the West Indies.
